Oaktree Acquisition Corp. III Life Sciences Income Statement (2024-2026) | OACC

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Other Operating Expenses (Quarter) 0.44M0.27M0.23M0.26M0.46M
Operating Expenses (Quarter) 0.44M0.27M0.23M0.26M0.46M
Operating Income (Quarter) -0.44M-0.27M-0.23M-0.26M-0.46M
EBIT (Quarter) -0.44M-0.27M-0.23M-0.26M-0.46M
Non-operating items
Interest & Investment Income (Quarter) 2.10M2.14M2.19M2.04M1.85M
Non Operating Income (Quarter) 2.10M2.14M2.19M2.04M1.85M
Net income details
EBT (Quarter) 1.66M1.87M1.97M1.79M1.39M
Profit After Tax (Quarter) 1.66M1.87M1.97M1.79M1.39M
Income from Continuing Operations (Quarter) 1.66M1.87M1.97M1.79M1.39M
Consolidated Net Income (Quarter) 1.66M1.87M1.97M1.79M1.39M
Income towards Parent Company (Quarter) 1.66M1.87M1.97M1.79M1.39M
Net Income towards Common Stockholders (Quarter) 1.66M1.87M1.97M1.79M1.39M
Additional items
EPS (Basic) (Quarter) 0.070.080.080.080.06
EPS (Weighted Average and Diluted) (Quarter) 0.070.080.080.080.06
Shares Outstanding (Weighted Average) (Quarter) 4.70M5.38M19.20M19.20M3.96M5.38M
EBITDA (Quarter) -0.44M-0.27M-0.23M-0.26M-0.46M
Shares Outstanding (Quarter) 0.58M4.80M4.80M4.80M4.80M4.80M